Jay S. Skyler

SCHOOL OF MEDICINE, MEDICINE

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

Jay S. Skyler

• Departments
  SCHOOL OF MEDICINE
  
  MEDICINE
  
  

  Current Appointments:

  Professor

  
  
  

3052436146

Available as Mentor - Not Indicated

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  J.S. Skyler

  Primary and secondary prevention of Type 1 diabetes

  Diabetic Medicine. 2013;30(2):161-169.
  1

• 2.

  2013

  Antoinette Moran; Brian Bundy; Dorothy J Becker; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Carla J Greenbaum; Kevan C Herold; Jennifer B Marks; Philip Raskin; et al.

  Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

  The Lancet. 2013.
  0

• 3.

  2012

  Satish K. Garg; Jay S. Skyler

  New medications for the treatment of diabetes

  International Journal of Clinical Practice. 2012;66(SUPPL. 175):85-93.
  0

• 4.

  2012

  Jay S. Skyler

  Type 1 diabetes mellitus: Immune intervention

  International Journal of Clinical Practice. 2012;66(SUPPL. 175):56-61.
  0

• 5.

  2012

  Moshe Phillip; Thomas Danne; Shlomit Shalitin; Bruce Buckingham; Lori Laffel; William Tamborlane; Tadej Battelino; Ragnar Hanas; Peter H. Chase; Stephen O'Riordan; et al.

  Use of continuous glucose monitoring in children and adolescents

  Pediatric Diabetes. 2012;13(3):215-228.
  9

• 6.

  2012

  Liping Yu; David C. Boulware; Craig A. Beam; John C. Hutton; Janet M. Wenzlau; Carla J. Greenbaum; Polly J. Bingley; Jeffrey P. Krischer; Jay M. Sosenko; Jay S. Skyler; et al.

  Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies

  Diabetes Care. 2012;35(6):1213-1218.
  5

• 7.

  2012

  Jay M. Sosenko; Jay S. Skyler; Kevan C. Herold; Jerry P. Palmer

  The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the diabetes prevention trial-type 1

  Diabetes. 2012;61(6):1331-1337.
  1

• 8.

  2012

  Jay M. Sosenko; Jay S. Skyler; Jeffrey Mahon; Jeffrey P. Krischer; Craig A. Beam; David C. Boulware; Carla J. Greenbaum; Lisa E. Rafkin; Catherine Cowie; David Cuthbertson; et al.

  The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes

  Diabetes Care. 2012;35(7):1552-1555.
  0

• 9.

  2012

  Gaetano Faleo; Carmen Fotino; Nicola Bocca; R. Damaris Molano; Elsie Zahr-Akrawi; Judith Molina; Susana Villate; Oliver Umland; Jay S. Skyler; Allison L. Bayer; et al.

  Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy

  Diabetes. 2012;61(7):1769-1778.
  1

• 10.

  2012

  Carla J. Greenbaum; Craig A. Beam; David Boulware; Stephen E. Gitelman; Peter A. Gottlieb; Kevan C. Herold; John M. Lachin; Paula McGee; Jerry P. Palmer; Mark D. Pescovitz; et al.

  Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes trialnet data

  Diabetes. 2012;61(8):2066-2073.
  5

• 11.

  2012

  Ping Xu; Craig A. Beam; David Cuthbertson; Jay M. Sosenko; Jay S. Skyler; Jeffrey P. Krischer

  Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population receiver operating characteristic analysis

  Diabetes Care. 2012;35(10):1975-1980.
  2

• 12.

  2012

  D. Han; X. Cai; J. Wen; D. Matheson; J.S. Skyler; N.S. Kenyon; Z. Chen

  Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes

  Clinical and Experimental Immunology. 2012;170(2):131-138.
  3

• 13.

  2011

  Jeffrey L. Mahon; Craig A. Beam; Santica M. Marcovina; David C. Boulware; Jerry P. Palmer; William E. Winter; Jay S. Skyler; Jeffrey P. Krischer

  Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies

  Clinica Chimica Acta. 2011;412(23-24):2128-2131.
  2

• 14.

  2011

  Jay M. Sosenko; Jay S. Skyler; Jerry P. Palmer; Jeffrey P. Krischer; David Cuthbertson; Liping Yu; Desmond A. Schatz; Tihamer Orban; George Eisenbarth

  A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in diabetes prevention trial-type 1 (DPT-1) participants

  Diabetes Care. 2011;34(11):2435-2437.
  2

• 15.

  2011

  Jay M. Sosenko; Jeffrey Mahon; Lisa Rafkin; John M. Lachin; Heidi Krause-Steinrauf; Jeffrey P. Krischer; David Cuthbertson; Jerry P. Palmer; Clinton Thompson; Carla J. Greenbaum; et al.

  A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants

  Pediatric Diabetes. 2011;12(2):85-90.
  0

• 16.

  2011

  Dongmei Han; Carlos A. Leyva; Della Matheson; Davide Mineo; Shari Messinger; Bonnie B. Blomberg; Ana Hernandez; Luigi F. Meneghini; Gloria Allende; Jay S. Skyler; et al.

  Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes

  Clinical Immunology. 2011;139(3):290-301.
  2

• 17.

  2011

  Diane K Wherrett; Brian Bundy; Dorothy J Becker; Linda A Dimeglio; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Carla J Greenbaum; Kevan C Herold; Jennifer B Marks; et al.

  Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: A randomised double-blind trial

  The Lancet. 2011;378(9788):319-327.
  52

• 18.

  2011

  Tihamer Orban; Brian Bundy; Dorothy J. Becker; Linda A. DiMeglio; Stephen E. Gitelman; Robin Goland; Peter A. Gottlieb; Carla J. Greenbaum; Jennifer B. Marks; Roshanak Monzavi; et al.

  Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled trial

  The Lancet. 2011;378(9789):412-419.
  52

• 19.

  2011

  John M. Lachin; Paula L. McGee; Carla J. Greenbaum; Jerry Palmer; Mark D. Pescovitz; Peter Gottlieb; Jay Skyler

  Sample size requirements for studies of treatment effects on Beta-Cell function in newly diagnosed type 1 diabetes

  PLoS ONE. 2011;6(11).
  2

• 20.

  2011

  J.S. Skyler

  Immune intervention for type 1 diabetes mellitus.

  International journal of clinical practice. Supplement. 2011;(170):61-70.
  7

• 21.

  2011

  Mark D. Pescovitz; Troy R. Torgerson; Hans D. Ochs; Elizabeth Ocheltree; Paula McGee; Heidi Krause-Steinrauf; John M. Lachin; Jennifer Canniff; Carla Greenbaum; Kevan C. Herold; et al.

  Effect of rituximab on human in vivo antibody immune responses

  Journal of Allergy and Clinical Immunology. 2011;128(6):1295-1302.e5.
  10

• 22.

  2011

  Jay M. Sosenko; Jay S. Skyler; Jeffrey Mahon; Jeffrey P. Krischer; Craig A. Beam; David C. Boulware; Carla J. Greenbaum; Lisa E. Rafkin; Catherine Cowie; David Cuthbertson; et al.

  Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study

  Diabetes Care. 2011;34(8):1785-1787.
  4

• 23.

  2011

  Kendra Vehik; Craig A. Beam; Jeffrey L. Mahon; Desmond A. Schatz; Michael J. Haller; Jay M. Sosenko; Jay S. Skyler; Jeffrey P. Krischer

  Development of autoantibodies in the TrialNet natural history study

  Diabetes Care. 2011;34(9):1897-1901.
  3

• 24.

  2011

  Jay S. Skyler; Camillo Ricordi

  Stopping type 1 diabetes: Attempts to prevent or cure type 1 diabetes in man

  Diabetes. 2011;60(1):1-8.
  28

• 25.

  2010

  Ping Xu; Yougui Wu; Yiliang Zhu; Getachew Dagne; Giffe Johnson; David Cuthbertson; Jeffrey P. Krischer; Jay M. Sosenko; Jay S. Skyler

  Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes

  Diabetes Care. 2010;33(12):2508-2513.
  4

• 26.

  2010

  Jay M. Sosenko; Jay S. Skyler; Jeffrey P. Krischer; Carla J. Greenbaum; Jeffrey Mahon; Lisa E. Rafkin; David Cuthbertson; Catherine Cowie; Kevan Herold; George Eisenbarth; et al.

  Glucose excursions between states of glycemia with progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1)

  Diabetes. 2010;59(10):2386-2389.
  6

• 27.

  2010

  J.S. Skyler

  Immunomodulation for type 1 diabetes mellitus.

  International journal of clinical practice. Supplement. 2010;(166):59-63.
  1

• 28.

  2010

  P. Aschner; E. Horton; L.A. Leiter; N. Munro; J.S. Skyler

  Practical steps to improving the management of type 1 diabetes: Recommendations from the Global Partnership for Effective Diabetes Management

  International Journal of Clinical Practice. 2010;64(3):305-315.
  9

• 29.

  2010

  J.S. Skyler

  Immunomodulation for type 1 diabetes mellitus: Advanced technologies and treatments for diabetes

  International Journal of Clinical Practice. 2010;64(SUPPL. 166):59-63.
  2

• 30.

  2010

  Mark D. Pescovitz; Jay S. Skyler

  The authors reply

  New England Journal of Medicine. 2010;362(8):761.
  0

• 31.

  2010

  Jay M. Sosenko; Jerry P. Palmer; Lisa E. Rafkin; Jeffrey P. Krischer; David Cuthbertson; Carla J. Greenbaum; George Eisenbarth; Jay S. Skyler

  Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants

  Diabetes Care. 2010;33(3):620-625.
  8

• 32.

  2010

  Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M. Sosenko; Jay S. Skyler

  Progression to diabetes in relatives of type 1 diabetic patients: Mechanisms and mode of onset

  Diabetes. 2010;59(3):679-685.
  14

• 33.

  2010

  Peter A. Gottlieb; Scott Quinlan; Heidi Krause-Steinrauf; Carla J. Greenbaum; Darrell M. Wilson; Henry Rodriguez; Desmond A. Schatz; Antoinette M. Moran; John M. Lachin; Jay S. Skyler

  Failure to preserve β-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new-onset type 1 diabetes

  Diabetes Care. 2010;33(4):826-832.
  40

• 34.

  2010

  Jay S. Skyler

  Continuous subcutaneous insulin infusion-An historical perspective

  Diabetes Technology and Therapeutics. 2010;12(SUPPL. 1):S5-S9.
  2

• 35.

  2010

  J.S. Skyler

  Glycemia and cardiovascular diseases in type 2 diabetes

  Journal of Internal Medicine. 2010;268(5):468-470.
  3

• 36.

  2009

  Jay S. Skyler; Richard Bergenstal; Robert O. Bonow; John Buse; Prakash Deedwania; Edwin A.M. Gale; Barbara V. Howard; M. Sue Kirkman; Mikhail Kosiborod; et al.

  Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association

  Journal of the American College of Cardiology. 2009;53(3):298-304.
  104

• 37.

  2009

  Jay S. Skyler

  CGM - A technology in evolution

  Diabetes Technology and Therapeutics. 2009;11(2):63-64.
  3

• 38.

  2009

  Jay S. Skyler; Richard Bergenstal; Robert O. Bonow; John Buse; Prakash Deedwania; Edwin A. M. Gale; Barbara V. Howard; M. Sue Kirkman; Mikhail Kosiborod; et al.

  Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

  Circulation. 2009;119(2):351-357.
  141

• 39.

  2009

  Jeffrey L Mahon; Jay M. Sosenko; Lisa Rafkin-Mervis; Heidi Krause-Steinrauf; John M. Lachin; Clinton Thompson; Polly J. Bingley; Ezio Bonifacio; Jerry P. Palmer; George S. Eisenbarth; et al.

  The TrialNet natural history study of the development of type 1 diabetes: Objectives, design, and initial results

  Pediatric Diabetes. 2009;10(2):97-104.
  29

• 40.

  2009

  Jay S. Skyler; Richard Bergenstal; Robert O. Bonow; John Buse; Prakash Deedwania; Edwin A.M. Gale; Barbara V. Howard; M. Sue Kirkman; Mikhail Kosiborod; Peter Reaven; et al.

  Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials

  Diabetes Care. 2009;32(1):187-192.
  208

• 41.

  2009

  Johanna R. Klaus; Barry E. Hurwitz; Maria M. Llabre; Jay S. Skyler; Ronald B. Goldberg; Jennifer B. Marks; Martin S. Bilsker; Neil Schneiderman

  Central obesity and insulin resistance in the cardiometabolic syndrome: Pathways to preclinical cardiovascular structure and function

  Journal of the CardioMetabolic Syndrome. 2009;4(2):63-71.
  6

• 42.

  2009

  J.S. Skyler; R. Bergenstal; R.O. Bonow; J. Buse; P. Deedwania; E.A.M. Gale; B.V. Howard; M.S. Kirkman; M. Kosiborod; et al.

  Erratum: Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association (Diabetes Care (2009) 32 (187-192))

  Diabetes Care. 2009;32(4):754.
  3

• 43.

  2009

  Wendy S Lane; Elaine K Cochran; Jeffrey A Jackson; Jamie L Scism-Bacon; Ilene B Corey; Irl B Hirsch; Jay S Skyler

  High-dose insulin therapy: is it time for U-500 insulin?

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2009;15(1):71-79.
  33

• 44.

  2009

  Jay S. Skyler

  Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: Response to Lund and Vaag

  Diabetes Care. 2009;32(7):e92-e93.
  2

• 45.

  2009

  Jay M. Sosenko; Jerry P. Palmer; Lisa Rafkin-Mervis; Jeffrey P. Krischer; David Cuthbertson; Jeffery Mahon; Carla J. Greenbaum; Catherine C. Cowie; Jay S. Skyler

  Incident dysglycemia and progression to type 1 diabetes among participants in the diabetes prevention trial-type 1

  Diabetes Care. 2009;32(9):1603-1607.
  9

• 46.

  2009

  Satish K. Garg; Irl B. Hirsch; Jay S. Skyler

  Editorial: Insulin glargine and cancer-an unsubstantiated allegation

  Diabetes Technology and Therapeutics. 2009;11(8):473-476.
  32

• 47.

  2009

  Jay S Skyler

  Continuous glucose monitoring: an overview of its development.

  Diabetes technology & therapeutics. 2009;11 Suppl 1:S5-10.
  22

• 48.

  2009

  Mark D. Pescovitz; Carla J. Greenbaum; Heidi Krause-Steinrauf; Dorothy J. Becker; Stephen E. Gitelman; Robin Goland; Peter A. Gottlieb; Jennifer B. Marks; Paula F. McGee; Antoinette M. Moran; et al.

  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

  New England Journal of Medicine. 2009;361(22):2143-2152.
  234

• 49.

  2009

  Tihamer Orban; Jay M. Sosenko; David Cuthbertson; Jeffrey P. Krischer; Jay S. Skyler; Richard Jackson; Liping Yu; Jerry P. Palmer; Desmond Schatz; George Eisenbarth

  Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1

  Diabetes Care. 2009;32(12):2269-2274.
  44

• 50.

  2009

  Simona Cernea; Itamar Raz; Kevan C. Herold; Boaz Hirshberg; Bart O. Roep; Desmond A. Schatz; G. Alexander Fleming; Paolo Pozzilli; Randie Little; et al.

  Challenges in developing endpoints for type 1 diabetes intervention studies

  Diabetes/Metabolism Research and Reviews. 2009;25(8):694-704.
  8

• 51.

  2008

  Jay S. Skyler

  Thirty years of Diabetes Care: Reflections on the beginning

  Diabetes Care. 2008;31(1):183-184.
  1

• 52.

  2008

  Stephen W. Ponder; Jay S. Skyler; Davida F. Kruger; Della Matheson; Bruce W. Brown

  Unexplained hyperglycemia in continuous subcutaneous insulin infusion: Evaluation and treatment

  Diabetes Educator. 2008;34(2):327-333.
  3

• 53.

  2008

  Jennifer Sherr; Jay Sosenko; Jay S. Skyler; Kevan C. Herold

  Prevention of type 1 diabetes: The time has come

  Nature Clinical Practice Endocrinology and Metabolism. 2008;4(6):334-343.
  23

• 54.

  2008

  Jay M. Sosenko; Jeffrey P. Krischer; Jerry P. Palmer; Jeffrey Mahon; Catherine Cowie; Carla J. Greenbaum; David Cuthbertson; John M. Lachin; Jay S. Skyler

  A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1

  Diabetes Care. 2008;31(3):528-533.
  24

• 55.

  2008

  Jay S. Skyler; Priscilla A. Hollander; Lois Jovanovic; Sol Klioze; Alan Krasner; Richard J. Riese; Joann Reis; Pamela Schwartz; William Duggan

  Safety and efficacy of inhaled human insulin (Exubera^®) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial

  Diabetes Research and Clinical Practice. 2008;82(2):238-246.
  11

• 56.

  2008

  Jay S. Skyler

  Latent autoimmune diabetes in adults: The search for interventions continues

  Nature Clinical Practice Endocrinology and Metabolism. 2008;4(11):600-601.
  1

• 57.

  2008

  Jay M. Sosenko; Jerry P. Palmer; Lisa Rafkin-Mervis; Jeffrey P. Krischer; David Cuthbertson; Della Matheson; Jay S. Skyler

  Glucose and C-peptide changes in the perionset period of type 1 diabetes in the diabetes prevention trial-type 1

  Diabetes Care. 2008;31(11):2188-2192.
  18

• 58.

  2008

  Jay S. Skyler; Carla J. Greenbaum; John M. Lachin; Ellen Leschek; Lisa Rafkin-Mervis; Peter Savage; Lisa Spain

  Type 1 diabetes TrialNet - An international collaborative clinical trials network

  Annals of the New York Academy of Sciences. 2008;1150:14-24.
  16

• 59.

  2008

  Jay S. Skyler

  Update on worldwide efforts to prevent type 1 diabetes

  Annals of the New York Academy of Sciences. 2008;1150:190-196.
  20

• 60.

  2007

  Jay M. Sosenko; Jerry P. Palmer; Carla J. Greenbaum; Jeffrey Mahon; Catherine Cowie; Jeffrey P. Krischer; H. Peter Chase; Neil H. White; Bruce Buckingham; Kevan C. Herold; et al.

  Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: The diabetes prevention trial-type 1

  Diabetes Care. 2007;30(1):38-42.
  25

• 61.

  2007

  Barry E. Hurwitz; Johanna R. Klaus; Maria M. Llabre; Alex Gonzalez; Peter J. Lawrence; Kevin J. Maher; Jeffrey M. Greeson; Marianna K. Baum; Gail Shor-Posner; Jay S. Skyler; et al.

  Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial

  Archives of Internal Medicine. 2007;167(2):148-154.
  65

• 62.

  2007

  Jay S. Skyler

  Response from Dr. Skyler [2]

  Clinical Diabetes. 2007;25(1):3-4.
  0

• 63.

  2007

  Jay S. Skyler; Lois Jovanovic; Sol Klioze; Joann Reis; William Duggan

  Two-year safety and efficacy of inhaled human insulin (exubera) in adult patients with type 1 diabetes

  Diabetes Care. 2007;30(3):579-585.
  54

• 64.

  2007

  Jay S. Skyler

  Cellular therapy for type 1 diabetes: Has the time come?

  Journal of the American Medical Association. 2007;297(14):1599-1600.
  12

• 65.

  2007

  J.S. Skyler

  Prediction and prevention of type 1 diabetes: Progress, problems, and prospects

  Clinical Pharmacology and Therapeutics. 2007;81(5):768-771.
  38

• 66.

  2007

  Jay S. Skyler; Steven Ponder; Davida F. Kruger; Della Matheson; Christopher G. Parkin

  Is there a place for insulin pump therapy in your practice?

  Clinical Diabetes. 2007;25(2):50-56.
  13

• 67.

  2007

  Jay S. Skyler

  Pulmonary insulin delivery - State of the art 2007

  Diabetes Technology and Therapeutics. 2007;9(SUPPL. 1):S-1-S-3.
  4

• 68.

  2006

  Jay M. Sosenko; Jerry P. Palmer; Carla J. Greenbaum; Jeffrey Mahon; Catherine Cowie; Jeffrey P. Krischer; H. Peter Chase; Neil H. White; Bruce Buckingham; Kevan C. Herold; et al.

  Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1

  Diabetes Care. 2006;29(3):643-649.
  65

• 69.

  2006

  Jay S. Skyler

  PROactive: A sad tale of inappropriate analysis and unjustified interpretation

  Clinical Diabetes. 2006;24(2):63-65.
  15

• 70.

  2005

  Jay S. Skyler

  Effects of oral insulin in relatives of patients with type 1 diabetes: The diabetes prevention trial-type 1

  Diabetes Care. 2005;28(5):1068-1076.
  245

• 71.

  2005

  Jay S. Skyler; Ruth S. Weinstock; Philip Raskin; Jean-Francois Yale; Eugene Barrett; John E. Gerich; Hertzel C. Gerstein

  Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: A 6-month, randomized, comparative trial

  Diabetes Care. 2005;28(7):1630-1635.
  150

• 72.

  2005

  Jay S. Skyler

  Pulmonary insulin update

  Diabetes Technology and Therapeutics. 2005;7(5):834-839.
  3

• 73.

  2004

  Barry E. Hurwitz; Nancy G. Klimas; Maria M. Llabre; Kevin J. Maher; Jay S. Skyler; Martin S. Bilsker; Shvawn McPherson-Baker; Peter J. Lawrence; Arthur R. LaPerriere; et al.

  HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk: Role of protease inhibitor exposure

  Cardiovascular Toxicology. 2004;4(3):303-315.
  11

• 74.

  2004

  Jay S. Skyler

  DCCT: The study that forever changed the nature of treatment of type 1 diabetes

  British Journal of Diabetes and Vascular Disease. 2004;4(1):29-32.
  1

• 75.

  2004

  J.P. Palmer; G.A. Fleming; C.J. Greenbaum; K.C. Herold; L.D. Jansa; H. Kolb; J.M. Lachin; K.S. Polonsky; P. Pozzilli; J.S. Skyler; et al.

  Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

  Diabetes. 2004;53(7):1934.
  0

• 76.

  2004

  Jay S. Skyler

  Diabetes mellitus: Pathogenesis and treatment strategies

  Journal of Medicinal Chemistry. 2004;47(17):4113-4117.
  87

• 77.

  2004

  Jerry P. Palmer; G. Alexander Fleming; Carla J. Greenbaum; Kevan C. Herold; Lisa D. Jansa; Hubert Kolb; John M. Lachin; Kenneth S. Polonsky; Paolo Pozzilli; Jay S. Skyler; et al.

  C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21-22 October 2001

  Diabetes. 2004;53(1):250-264.
  159

• 78.

  2002

  Jay S. Skyler; Carolyn Oddo

  Diabetes trends in the USA

  Diabetes/Metabolism Research and Reviews. 2002;18(SUPPL. 3):S21-S26.
  70

• 79.

  2002

  J.S. Skyler; D. Brown; H.P. Chase; E. Collier; C. Cowie; G.S. Eisenbarth; J. Fradkin; G. Grave; C. Greenbaum; R.A. Jackson; et al.

  Effects of insulin in relatives of patients with type 1 diabetes mellitus

  New England Journal of Medicine. 2002;346(22):1685-1691.
  394

• 80.

  2001

  J.S. Skyler

  Microvascular complications: Retinopathy and nephropathy

  Endocrinology and Metabolism Clinics of North America. 2001;30(4):833-856.
  31

• 81.

  2001

  Jay S Skyler; William T Cefalu; Ione A Kourides; William H Landschulz; Cecile C Balagtas; Shu-Lin Cheng; Robert A Gelfand

  Efficacy of inhaled human insulin in type 1 diabetes mellitus: A randomised proof-of-concept study

  Lancet. 2001;357(9253):331-335.
  257

• 82.

  2001

  W.T. Cefalu; J.S. Skyler; I.A. Kourides; W.H. Landschulz; C.C. Balagtas; S.-L. Cheng; R.A. Gelfand

  Inhaled human insulin treatment in patients with type 2 diabetes mellitus

  Annals of Internal Medicine. 2001;134(3):203-207+I54.
  185

• 83.

  2001

  Rita Z. Goldstein; Barry E. Hurwitz; Maria M. Llabre; Neil Schneiderman; Miriam Gutt; Jay S. Skyler; Ronald J. Prineas; Richard P. Donahue

  Modeling preclinical cardiovascular risk for use in epidemiologic studies: Miami community health study

  American Journal of Epidemiology. 2001;154(8):765-776.
  5

• 84.

  2000

  Arlan L. Rosenbloom; Desmond A. Schatz; Jeffrey P. Krischer; Jay S. Skyler; Dorothy J. Becker; Ronald E. LaPorte; Ingrid Libman; Massimo Pietropaolo; Hans-Michael Dosch; Laurence Finberg; et al.

  Therapeutic controversy: Prevention and treatment of diabetes in children

  Journal of Clinical Endocrinology and Metabolism. 2000;85(2):494-522.
  41

• 85.

  2000

  B. Feldman; G. McGarraugh; A. Heller; N. Bohannon; J. Skyler; E. DeLeeuw; D. Clarke

  Freestyle(TM): A small-volume electrochemical glucose sensor for home blood glucose testing

  Diabetes Technology and Therapeutics. 2000;2(2):221-229.
  33

• 86.

  2000

  Miriam Gutt; Catherine L. Davis; Susan B. Spitzer; Maria M. Llabre; Mahendra Kumar; Eileen M. Czarnecki; Neil Schneiderman; Jay S. Skyler; Jennifer B. Marks

  Validation of the insulin sensitivity index (ISI_0,120): Comparison with other measures

  Diabetes Research and Clinical Practice. 2000;47(3):177-184.
  177

• 87.

  2000

  J.S. Skyler

  Continuous glucose monitoring symposium

  Diabetes Technology and Therapeutics. 2000;2(SUPPL. 1):S5.
  0

• 88.

  2000

  J.S. Skyler

  The economic burden of diabetes and the benefits of improved glycemic control: The potential role of a continuous glucose monitoring system

  Diabetes Technology and Therapeutics. 2000;2(SUPPL. 1):S7-S12.
  9

• 89.

  1999

  H. Beck-Nielsen; J. Skyler; M. Hanefeld; E. Eschwege; J.-R. Finn; R. DeFronzo; S. Del Prato; P. Bjorntorp; L. Groop; H. Haring; et al.

  Discussion

  Drugs. 1999;58(SUPPL. 1):75-82.
  3

• 90.

  1999

  Catherine L. Davis; Miriam Gutt; Maria M. Llabre; Jennifer B. Marks; Mary J. O'Sullivan; Jonell E. Potter; Julie L. Landel; Mahendra Kumar; Neil Schneiderman; Marc Gellman; et al.

  History of gestational diabetes, insulin resistance and coronary risk

  Journal of Diabetes and its Complications. 1999;13(4):216-223.
  33

• 91.

  1999

  Sarosh J. Motivala; Barry E. Hurwitz; Annette M. LaGreca; Maria M. Llabre; Jennifer B. Marks; Jay S. Skyler; Neil Schneiderman

  Aberrant parasympathetic and hemodynamic function distinguishes a subgroup of psychologically distressed individuals with asymptomatic type-I diabetes mellitus

  International Journal of Behavioral Medicine. 1999;6(1):78-94.
  4

• 92.

  1999

  Richard P. Donahue; Paul Zimmet; Judy A. Bean; Maximilian Decourten; Rosemary A. Decarlo Donahue; Gregory Collier; Ronald B. Goldberg; Ronald J. Prineas; Jay Skyler; et al.

  Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami community health study

  Annals of Epidemiology. 1999;9(2):108-113.
  61

• 93.

  1999

  Richard P. Donahue; Ronald J. Prineas; Rosemary DeCarlo Donahue; Paul Zimmet; Judy A. Bean; Maximilian De Courten; Gregory Collier; Ronald B. Goldberg; Jay S. Skyler; Neil Schneiderman

  Is fasting leptin associated with insulin resistance among nondiabetic individuals?: The Miami Community Health Study

  Diabetes Care. 1999;22(7):1092-1096.
  57

• 94.

  1998

  J.S. Skyler

  Simplifying the diagnosis of diabetes mellitus

  American Family Physician. 1998;58(6):1290-1292.
  0

• 95.

  1998

  A. Rabinovitch; J.S. Skyler

  Prevention of type 1 diabetes

  Medical Clinics of North America. 1998;82(4):739-755.
  32

• 96.

  1998

  J.S. Skyler

  Preface: Prevention and treatment of diabetes and its complications

  Medical Clinics of North America. 1998;82(4):xi-xii.
  0

• 97.

  1998

  G.W. Burke; G. Ciancio; R. Alejandro; D. Roth; C. Ricordi; J.S. Skyler; A. Tzakis; J. Miller

  Cholesterol control: Long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression

  Transplantation Proceedings. 1998;30(2):513-514.
  11

• 98.

  1998

  Richard P. Donahue; Ronald J. Prineas; Judy A. Bean; Rosemary A. Decarlo Donahue; Ronald B. Goldberg; Jay S. Skyler; Neil Schneiderman

  The relation of fasting insulin to blood pressure in a multiethnic population: The Miami Community Health Study

  Annals of Epidemiology. 1998;8(4):236-244.
  7

• 99.

  1998

  J.S. Skyler

  Targeted glycemic control in type 2 diabetes.

  The Journal of the Florida Medical Association. 1998;85(2):7-15.
  1

• 100.

  1997

  J.S. Skyler

  Glucose control in type 2 diabetes mellitus

  Annals of Internal Medicine. 1997;127(9):837-839.
  8

• 101.

  1997

  J.S. Skyler

  Insulin therapy in type II diabetes

  SENDROM. 1997;9(10):66-73.
  0

• 102.

  1997

  J.S. Skyler

  Tactics for type I diabetes

  Endocrinology and Metabolism Clinics of North America. 1997;26(3):647-657.
  6

• 103.

  1997

  J.S. Skyler

  Insulin therapy in type II diabetes: Who needs it, how much of it, and for how long?

  Postgraduate Medicine. 1997;101(2):85-90+92-94+96.
  12

• 104.

  1997

  G.W. Burke; C. Ricordi; T. Karatzas; M. Carreno; M. Markou; R. Cirocco; G. Ciancio; T. Qian; G. Selvaggi; R. Alejandro; et al.

  Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: Evidence for augmentation of chimerism

  Transplantation Proceedings. 1997;29(1-2):1207-1208.
  17

• 105.

  1996

  J.S. Skyler

  Diabetic complications: The importance of glucose control

  Endocrinology and Metabolism Clinics of North America. 1996;25(2):243-254.
  78

• 106.

  1996

  R.P. Donahue; R.J. Prineas; R. DeCarlo Donahue; J.A. Bean; J.S. Skyler

  The female 'insulin advantage' in a biracial cohort: Results from the Miami Community Health Study

  International Journal of Obesity. 1996;20(1):76-82.
  28

• 107.

  1996

  D.C. Robbins; L. Andersen; R. Bowsher; R. Chance; B. Dinesen; B. Frank; R. Gingerich; D. Goldstein; H.-M. Widemeyer; S. Haffner; et al.

  Report of the American Diabetes Association's task force on standardization of the insulin assay

  Diabetes. 1996;45(2):242-256.
  119

• 108.

  1996

  Richard P. Donahue; Rosemary A. DeCarlo Donahue; Ronald J. Prineas; Judy Bean; Miriam Gutt; Jay S. Skyler; Neil Schneiderman

  Insulin sensitivity and blood pressure in a biethnic sample: The Miami Community Health Study

  Journal of Clinical Epidemiology. 1996;49(8):859-864.
  9

• 109.

  1996

  G. Boner; D.J. Van Dyk; M.H. Tan; J. Tan; A. Ekstrand; V.A. Koivisto; L.C. Groop; P.H. Groop; A. Lucas; R. Romero; et al.

  Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria

  Diabetologia. 1996;39(5):587-593.
  173

• 110.

  1995

  Jay S. Skyler; Jennifer B. Marks; Neil Schneiderman

  Hypertension in patients with diabetes mellitus

  American Journal of Hypertension. 1995;8(12 PART 2):100S-105S.
  14

• 111.

  1995

  G.W. Burke; C. Ricordi; T. Karatzas; M. Carreno; R. Cirocco; G. Ciancio; D. Coker; T. Quian; G. Selvaggi; et al.

  Donor bone marrow infusion in simultaneous pancreas/kidney transplant recipients: A preliminary study

  Transplantation Proceedings. 1995;27(6):3121-3122.
  11

• 112.

  1995

  G.W. Burke; R. Alejandro; G. Ciancio; J. Nery; D. Roth; R. Shapiro; V. Scantlebury; J.S. Skyler; C. Ricordi; A. Tzakis; et al.

  The use of FK506 in simultaneous pancreas/kidney transplantation: Rescue, induction, and maintenance immunosuppression

  Transplantation Proceedings. 1995;27(6):3123-3124.
  16

• 113.

  1995

  G.W. Burke; R. Alejandro; D. Roth; J. Colona; N. Contreras; G. Ciancio; J.S. Skyler; C. Ricordi; J. Nery; et al.

  Use of FK 506 in simultaneous pancreas/kidney transplantation: Lack of impairment of glycemic or lipid metabolism

  Transplantation Proceedings. 1995;27(6):3119-3120.
  15

• 114.

  1994

  H. Akerblom; K.G.M.M. Alberti; S. Baba; P.H. Bennett; I. Dedov; H. Keen; R. Klein; J. Nerup; P. Xiao-Ren; F.E. Puchulu; et al.

  Prevention of diabetes mellitus

  World Health Organization - Technical Report Series. 1994;(844):i-100.
  0

• 115.

  1994

  J. Radziuk; S. Pye; D.E. Seigler; J.S. Skyler; R. Offord; G. Davies

  Splanchnic and systemic absorption of intraperitoneal insulin using a new double-tracer method

  AM.J.PHYSIOL. 1994;266(5 part 1):E750-E759.
  1

• 116.

  1994

  G.W. Burke; R. Cirocco; M. Markou; R.F. Agramonte; A. Rabinovitch; J. Miller; J.S. Skyler

  Effect of cyclosporine a on serum tumor necrosis factor α in new-onset type I (insulin-dependent) diabetes mellitus

  Journal of Diabetes and its Complications. 1994;8(1):40-44.
  4

• 117.

  1994

  J. Radziuk; S. Pye; D.E. Seigler; J.S. Skyler; R. Offord; G. Davies

  Splanchnic and systemic absorption of intraperitoneal insulin using a new double-tracer method

  American Journal of Physiology - Endocrinology and Metabolism. 1994;266(5 29-5):E750-E759.
  4

• 118.

  1994

  G.W. Burke; R. Alejandro; J. Nery; D. Roth; J.S. Skyler; C. Ricordi; G. Ciancio; J. Miller

  Combined kidney/pancreas transplantation in diabetes mellitus.

  Journal of the Florida Medical Association. 1994;81(5):339-343.
  5

• 119.

  1994

  L.C. Deeb; J.S. Skyler

  Upgrading diabetes therapy. Now that we know it matters.

  Journal of the Florida Medical Association. 1994;81(9):599-602.
  0

• 120.

  1994

  Barry E. Hurwitz; Ruth E. Quilhan; Jennifer B. Marks; Neil Schneiderman; Robert F. Agramonte; Charles R. Freeman; Annette M.La Greca; Jay S. Skyler

  Resting parasympathetic status and cardiovascular response to orthostatic and behavioral challenges in type I insulin-dependent diabetes mellitus

  International Journal of Behavioral Medicine. 1994;1(2):137-162.
  2

• 121.

  1993

  J.S. Skyler; T.J. Lorenz; S. Schwartz; G.S. Eisenbarth; D. Einhorn; J.P. Palmer; J.B. Marks; C. Greenbaum; E.A. Saria; et al.

  Effects of an anti-CD5 immunoconjugate (CD5-Plus) in recent onset type I diabetes mellitus: A preliminary investigation

  Journal of Diabetes and its Complications. 1993;7(4):224-232.
  14

• 122.

  1993

  J.S. Skyler

  The winds of change

  Diabetes. 1993;42(5):637-642.
  2

• 123.

  1993

  J.S. Skyler

  Human insulin after 10 years

  Diabetes Care. 1993;16(3 SUPPL. 3):1-3.
  2

• 124.

  1993

  J.S. Skyler

  SSCI presidential address: challenges of the future.

  American Journal of the Medical Sciences. 1993;306(1):5-9.
  0

• 125.

  1992

  D.E. Seigler; G.M. Olsson; J.S. Skyler

  Morning versus bedtime isophane insulin in Type 2 (non-insulin dependent) diabetes mellitus

  Diabetic Medicine. 1992;9(9):826-833.
  8

• 126.

  1992

  Jay S. Skyler; Alexander Rabinovitch

  Cyclosporine in recent onset type I diabetes mellitus. Effects on islet β cell function

  Journal of Diabetes and Its Complications. 1992;6(2):77-88.
  22

• 127.

  1992

  I.B. Hirsch; R. Farkas-Hirsch; J.S. Herbst; J.S. Skyler

  The effect of ejaculation on albumin excretion rate

  Journal of Diabetes and its Complications. 1992;6(3):163-165.
  2

• 128.

  1992

  J.S. Skyler; P. Raskin; M.D. Siperstein

  Is tight blood sugar control effective and justified?

  Hospital Practice. 1992;27(SUPPL. 1):17-25.
  0

• 129.

  1991

  J.S. Skyler

  Strategies in diabetes mellitus: Start of a new era

  Postgraduate Medicine. 1991;89(6):45-46+49+53.
  0

• 130.

  1991

  R. Martinez; B. Rietberg; J. Skyler; J.R. Oster; G.O. Perez

  Effect of hyperkalemia on insulin secretion

  Experientia. 1991;47(3):270-272.
  9

• 131.

  1991

  J.B. Marks; J.S. Skyler

  Clinical review 17: Immunotherapy of type I diabetes mellitus

  Journal of Clinical Endocrinology and Metabolism. 1991;72(1):3-9.
  8

• 132.

  1991

  R.J. Jarrett; R.P. Dohne; J.S. Skyler; N. Schneiderman; R.J. Prineas

  RE: ''Hyperinsulinemia and elevated blood pressure: Cause, confounder, or coincidence?'' [3]

  American Journal of Epidemiology. 1991;134(3):327-329.
  7

• 133.

  1991

  A. Peckerman; P.G. Saab; P.M. McCabe; J.S. Skyler; R.W. Winters; M.M. Llabre; N. Schneiderman

  Blood pressure reactivity and perception of pain during the forehead cold pressor test

  Psychophysiology. 1991;28(5):485-495.
  48

• 134.

  1991

  D.E. Seigler; G.M. Olsson; R.F. Agramonte; V.L. Lohman; M.H. Ashby; M.L. Reeves; J.S. Skyler

  Pharmacokinetics of long-acting (ultralente) insulin preparations

  Diabetes, Nutrition and Metabolism - Clinical and Experimental. 1991;4(4):267-273.
  11

• 135.

  1991

  Richard P. Donahue; Jay S. Skyler; Neil Schneiderman; Ronald J. Prineas

  The authors reply

  American Journal of Epidemiology. 1991;134(3):328-329.
  0

• 136.

  1990

  R.P. Donahue; J.S. Skyler; N. Schneiderman; R.J. Prineas

  Hyperinsulinemia and elevated blood pressure: Cause, confounder, or coincidence?

  American Journal of Epidemiology. 1990;132(5):827-836.
  34

• 137.

  1990

  J.S. Skyler; M.D. Fili

  Intensive therapy of type I diabetes: 1988

  Current status of prevention and treatment of diabetic complications: proceedings of the Third International Symposium on treatment of Diabetes Mellitus. ICS821. 1990:235-242.
  0

• 138.

  1990

  I.B. Hirsch; R. Farkas-Hirsch; J.S. Skyler

  Intensive insulin therapy for treatment of type I diabetes

  Diabetes Care. 1990;13(12):1265-1283.
  43

• 139.

  1989

  J.S. Skyler

  Issues, controversies and directions in diabetes care

  Diabetes 1988: proceedings of the 13th Congress of the International Diabetes Federation. ICS800. 1989:793- 801.
  1

• 140.

  1989

  W. Satin; A.M. La Greca; M.A. Zigo; J.S. Skyler

  Diabetes in adolescence: Effects of multifamily group intervention and parent simulation of diabetes

  Journal of Pediatric Psychology. 1989;14(2):259-275.
  85

• 141.

  1989

  H. Kolb; J.-F. Bach; G.S. Eisenbarth; L.C. Harrison; N.K. Maclaren; P. Pozzilli; J.S. Skyler; C.R. Stiller

  Criteria for immune trials in type I diabetes

  Lancet. 1989;2(8664):686.
  6

• 142.

  1989

  J.S. Skyler

  Intensive insulin therapy: a personal and historical perspective.

  The Diabetes educator. 1989;15(1):33-39.
  2

• 143.

  1988

  M. Bergman; S.A. Newman; T.B. Seaton; P. Felig; J.L. Kitzmiller; E.K. Main; J.S. Skyler; E. Miller; J.L. Mills; B.E. Metzger; et al.

  Diabetic control and fetal malformation

  New England Journal of Medicine. 1988;319(10):647-649.
  1

• 144.

  1988

  M.T. Gadia; J.S. Skyler; J.M. Sosenko

  The association between heart rate and glycemia in adult diabetic subjects

  Diabetes Research and Clinical Practice. 1988;5(1):25-29.
  1

• 145.

  1988

  A.J.M. Boulton; R.G. Cutfield; D. Abouganem; E. Angus; H.W. Flynn Jr.; J.S. Skyler; N.S. Penneys

  Necrobiosis lipoidica diabeticorum: A clinicopathologic study

  Journal of the American Academy of Dermatology. 1988;18(3):530-537.
  29

• 146.

  1988

  J.S. Skyler

  Insulin pharmacology.

  Medical Clinics of North America. 1988;72(6):1337-1354.
  10

• 147.

  1987

  J.S. Skyler

  Insulin-dependent diabetes mellitus. Flexibility in contemporary management

  Postgraduate Medicine. 1987;81(6):163-174.
  0

• 148.

  1987

  M.T. Gadia; N. Natori; L.B. Ramos; D.R. Ayyar; J.S. Skyler; J.M. Sosenko

  Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy

  Diabetes Care. 1987;10(5):613-616.
  26

• 149.

  1987

  J.S. Skyler

  Immune intervention studies in insulin-dependent diabetes mellitus

  Diabetes/Metabolism Reviews. 1987;3(4):1017-1035.
  8

• 150.

  1987

  R. Harris; M.W. Linn; J.S. Skyler; R. Sandifer

  Development of the diabetes health belief scale.

  The Diabetes educator. 1987;13(3):292-297.
  20

• 151.

  1987

  J.S. Skyler

  Why control blood glucose? Influence on chronic complications of diabetes.

  Pediatric Annals. 1987;16(9):713, 716-719, 723-724.
  2

• 152.

  1987

  J.S. Skyler; A. Rabinovitch

  Etiology and pathogenesis of insulin dependent diabetes mellitus.

  Pediatric Annals. 1987;16(9):682-683, 686.
  1

• 153.

  1987

  J.M. Sosenko; A.J.M. Boulton; M.T. Gadia; J.D. Ward; J.S. Skyler

  The association between symptomatic sensory neuropathy and body stature in diabetic patients

  Diabetes Research and Clinical Practice. 1987;4(2):95-98.
  8

• 154.

  1987

  J.M. Sosenko; M.T. Gadia; N. Natori; D.R. Ayyar; L.B. Ramos; J.S. Skyler

  Neurofunctional testing for the detection of diabetic peripheral neuropathy

  Archives of Internal Medicine. 1987;147(10):1741-1744.
  15

• 155.

  1986

  Arthur M. Fournier; Maria T. Gadia; Denise B. Kubrusly; Jay S. Skyler; Jay M. Sosenko

  Blood pressure, insulin, and glycemia in nondiabetic subjects

  The American Journal of Medicine. 1986;80(5):861-864.
  39

• 156.

  1986

  A.J.M. Boulton; D.B. Kubrusly; J.H. Bowker; M.T. Gadia; L. Quintero; D.M. Becker; J.S. Skyler; J.M. Sosenko

  Impaired vibratory perception and diabetic foot ulceration

  Diabetic Medicine. 1986;3(4):335-337.
  89

• 157.

  1986

  A.J.M. Boulton; J.H. Bowker; M. Gadia; R. Lemerman; K. Caswell; J.S. Skyler; J.M. Sosenko

  Use of plaster casts in the management of diabetic neuropathic foot ulcers

  Diabetes Care. 1986;9(2):149-152.
  37

• 158.

  1986

  J.M. Sosenko; D.B. Kubrusly; R.B. Goldberg; A.M. Fournier; S.L. Hsia; M.T. Gadia; J.S. Skyler

  High-density lipoprotein and glycosylated hemoglobin in nondiabetic individuals

  Archives of Internal Medicine. 1986;146(8):1521-1524.
  3

• 159.

  1986

  J.S. Skyler

  Control of diabetes during pregnancy: 1985

  Journal of the American Medical Association. 1986;255(5):647-648.
  0

• 160.

  1986

  Jay M. Sosenko; Maria T. Gadia; Arthur M. Fournier; Mark T. O'Connell; Maria C. Aguiar; Jay S. Skyler

  Body stature as a risk factor for diabetic sensory neuropathy

  The American Journal of Medicine. 1986;80(6):1031-1034.
  31

• 161.

  1986

  J.S. Skyler

  Lessons from studies of insulin pharmacokinetics

  Diabetes Care. 1986;9(6):666-668.
  14

• 162.

  1985

  E.A. Ryan; M.J. O'Sullivan; J.S. Skyler

  Insulin action during pregnancy: Studies with the euglycemic clamp technique

  Diabetes. 1985;34(4):380-389.
  154

• 163.

  1985

  Ronald B. Goldberg; Michael L. Reeves; Deborah E. Seigler; Edward A. Ryan; Nadine Miller; Sung L. Hsia; Jay S. Skyler

  Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment

  Acta Diabetologica Latina. 1985;22(2):93-101.
  0

• 164.

  1985

  A.L. Rosenbloom; J.I. Malone; A.D. Morrison; J.S. Skyler

  Screening for diabetes mellitus.

  The Journal of the Florida Medical Association. 1985;72(12):1033-1037.
  0

• 165.

  1985

  J.M. Sosenko; A.J.M. Boulton; D.B. Kubrusly; J.K. Weintraub; J.S. Skyler

  The vibratory perception threshold in young diabetic patients: Associations with glycemia and puberty

  Diabetes Care. 1985;8(6):605-607.
  23

• 166.

  1984

  J.S. Skyler; C.M. Beatty; R.B. Goldberg

  Managing diabetes: An updated look at diet

  Geriatrics. 1984;39(7):57-68.
  0

• 167.

  1984

  J.S. Skyler

  Non-insulin-dependent diabetes mellitus: A clinical strategy

  Diabetes Care. 1984;7(SUPPL. 1):118-128.
  5

• 168.

  1984

  B.B. Duncan; M.I. Schmidt; J.S. Skyler; G.J. Ellis III; A. Keller; M.H. Rathjens

  The flashlight test lacks validity as a screen for nocturnal hypoglycemia

  Diabetes Care. 1984;7(3):269-272.
  0

• 169.

  1984

  M.L. Reeves; D.E. Seigler; D.R. Ayyar; J.S. Skyler

  Medial plantar sensory response. Sensitive indicator of peripheral nerve dysfunction in patients with diabetes mellitus

  American Journal of Medicine. 1984;76(5):842-846.
  4

• 170.

  1983

  M.W. Linn; B.S. Linn; J.S. Skyler; J. Jensen

  Stress and immune function in diabetes mellitus

  Clinical Immunology and Immunopathology. 1983;27(2):223-233.
  10

• 171.

  1983

  E.A. Ryan; J. Miller; J.S. Skyler

  Finger sepsis: Possible complication of self monitoring of blood glucose concentrations

  British Medical Journal. 1983;286(6378):1614-1615.
  4

• 172.

  1983

  J.S. Skyler

  Dietary planning in insulin-dependent diabetes mellitus.

  Pediatric Annals. 1983;12(9):652-657.
  0

• 173.

  1982

  E.A. Ryan; E. Brower; M.J. O'Sullivan; J.S. Skyler

  Insulin resistance in pregnancy

  Diabetes. 1982;31(2 II Suppl. 2):No. 124.
  0

• 174.

  1982

  M.L. Reeves; D.E. Seigler; E.A. Ryan; J.S. Skyler

  Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion

  American Journal of Medicine. 1982;72(4):673-680.
  14

• 175.

  1982

  J.S. Skyler; D.E. Seigler; M.L. Reeves

  Optimizing pumped insulin delivery

  Diabetes Care. 1982;5(2):135-139.
  4

• 176.

  1982

  L.S. Lieberman; A.L. Rosenbloom; B. O'Malley; J.I. Malone; J.S. Skyler

  Institutionally-based diabetes educational services for patients and their families in Florida

  Journal of the Florida Medical Association. 1982;69(1):23-31.
  0

• 177.

  1982

  J.S. Skyler

  Diabetic retinopathy

  Journal of the American Medical Association. 1982;247(23):3246-3247.
  0

• 178.

  1982

  D. Seigler; M.L. Reeves; J.S. Skyler

  Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell function

  Diabetes Care. 1982;5(3):334-336.
  0

• 179.

  1982

  J.S. Skyler; D.E. Seigler; M.L. Reeves

  A comparison of insulin regimens in insulin-dependent diabetes mellitus

  Diabetes Care. 1982;5(Suppl. 1):11-18.
  3

• 180.

  1982

  D.E. Seigler; A. LaGreca; W.S. Citrin; M.L. Reeves; J.S. Skyler

  Psychological effects of intensification of diabetic control

  Diabetes Care. 1982;5(Suppl. 1):19-23.
  7

• 181.

  1982

  J.S. Skyler

  Human insulin of recombinant DNA origin: Clinical potential

  Diabetes Care. 1982;5(Suppl. 2):181-186.
  0

• 182.

  1982

  J.S. Skyler

  Self-monitoring of blood glucose

  Medical Clinics of North America. 1982;66(6):1227-1250.
  8

• 183.

  1982

  E.A. Ryan; E. Brower; M.J. O'Sullivan; J.S. Skyler

  Changes in insulin action associated with pregnancy

  Diabetologia. 1982;23(5):67.
  0

• 184.

  1982

  J.S. Skyler

  Management of diabetic retinopathy.

  Journal of the American Medical Association. 1982;248(22):2970-2971.
  0

• 185.

  1981

  Jay S. Skyler; George F. Cahill Jr.

  Foreword diabetes mellitus: Progress and directions

  The American Journal of Medicine. 1981;70(1):101-104.
  2

• 186.

  1981

  J.S. Skyler; F.A. Neelson

  An algebra for adiposity?

  Diabetes Care. 1981;4(2):328-329.
  0

• 187.

  1981

  J.S. Skyler

  Evidence, implications, and corollaries.

  Diabetes Care. 1981;4(5):573-575, 1214.
  0

• 188.

  1981

  J.S. Skyler; D.L. Skyler; D.E. Seigler; M.J. O'Sullivan

  Algorithms for adjustment of insulin dosage by patients who monitor blood glucose

  Diabetes Care. 1981;4(2):311-318.
  59

• 189.

  1981

  J.S. Skyler; E.F. Pfeiffer; S. Raptis; G.C. Viberti

  Biosynthetic human insulin: Progress and prospects

  Diabetes Care. 1981;4(2):140-143.
  0

• 190.

  1981

  M.L. Reeves; S.E. Forhan; J.S. Skyler; C.M. Peterson

  Comparison of methods for blood glucose monitoring

  Diabetes Care. 1981;4(3):404-406.
  2

• 191.

  1980

  J.S. Skyler; K.G.M.M. Alberti

  Clinical assessment of metabolic control in insulin-dependent diabetes mellitus

  Diabetes Care. 1980;3(2):369-370.
  0

• 192.

  1980

  J.S. Skyler; M.J. O'Sullivan; E.G. Robertson; D.L. Skyler; K.K. Holsinger; I.A. Lasky; A.G. McLeod; G. Burkett; D.H. Mintz

  Blood glucose control during pregnancy

  Diabetes Care. 1980;3(1):69-76.
  5

• 193.

  1980

  W. Citrin; G.J. Ellis III; J.S. Skyler

  Glycosylated hemoglobin: A tool in identifying psychological problems?

  Diabetes Care. 1980;3(4):563-564.
  1

• 194.

  1980

  D.C. Jimerson; R.M. Post; D.P. van Kammen; J.S. Skyler; G.L. Brown; W.E. Bunney Jr.

  Cerebrospinal fluid cortisol levels in depression and schizophrenia.

  American Journal of Psychiatry. 1980;137(8):979-980.
  0

• 195.

  1980

  J.S. Skyler; N.E. Miller

  The use of sweeteners by diabetic patients

  Practical Cardiology. 1980;6(10):119-129.
  0

• 196.

  1980

  M.W. Linn; B.S. Linn; J.S. Skyler; R. Harris

  The importance of self-assessed health in patients with diabetes

  Diabetes Care. 1980;3(5):599-606.
  6

• 197.

  1980

  J.S. Skyler; M.J. O'Sullivan; K.K. Holsinger

  The relationship between maternal glycemia and macrosomia

  Diabetes Care. 1980;3(3):433-434.
  2

• 198.

  1979

  J.S. Skyler

  Thoughts along the way.

  Diabetes Care. 1979;2(1):58-59.
  1

• 199.

  1979

  J.S. Skyler

  Diabetes and exercise: clinical implications.

  Diabetes Care. 1979;2(3):307-311.
  3

• 200.

  1979

  J.S. Skyler

  The spectrum of insulin resistance.

  Diabetes Care. 1979;2(3):319-322.
  0

• 201.

  1979

  J.S. Skyler

  Complications of diabetes mellitus: Relationship to metabolic dysfunction

  Diabetes Care. 1979;2(6):499-509.
  3

• 202.

  1979

  J.S. Skyler; G.J. Ellis; D.L. Skyler; I.A. Lasky; F.L. Lebovitz

  Instructing patients in making alterations in insulin dosage

  Diabetes Care. 1979;2(1):39-45.
  2

• 203.

  1979

  J.S. Skyler

  Counterregulatory hormones, rebound hyperglycemia, and diabetic control

  Diabetes Care. 1979;2(6):526-529.
  0

• 204.

  1978

  D.H. Mintz; J.S. Skyler; R.A. Chez

  Diabetes mellitus and pregnancy.

  Diabetes Care. 1978;1(1):49-63.
  4

• 205.

  1978

  J.S. Skyler

  Lipids, diet, diabetes, and atherogenesis.

  Diabetes Care. 1978;1(2):138-139.
  0

• 206.

  1978

  G.W. Blankenship; J.S. Skyler

  Diabetic retinopathy: a general survey.

  Diabetes Care. 1978;1(2):127-137.
  2

• 207.

  1978

  J.S. Skyler

  Sulfonylurea drugs 1978.

  Diabetes Care. 1978;1(3):205-206.
  0

• 208.

  1978

  J.S. Skyler

  "Control" and diabetic complications.

  Diabetes Care. 1978;1(3):204-205.
  1

• 209.

  1978

  J.S. Skyler

  The UGDP and insulin therapy.

  Diabetes Care. 1978;1(5):328-329.
  2

• 210.

  1978

  J.S. Skyler; I.A. Lasky; D.L. Skyler; E.G. Robertson; D.H. Mintz

  Home blood glucose monitoring as an aid in diabetes management

  Diabetes Care. 1978;1(3):150-157.
  13

• 211.

  1978

  F.L. Lebovitz; G.J. Ellis III; J.S. Skyler

  Performance of technical skills of diabetes management: Increased independence after a camp experience

  Diabetes Care. 1978;1(1):23-26.
  5

• 212.

  1977

  J.S. Skyler; G. Baumann; A. Chrambach

  A catalogue of isohormones of human growth hormone based on quantitative polyacrylamide gel electrophoresis.

  Acta Endocrinologica, Supplement. 1977;211:5-40.
  0

• 213.

  1977

  J.S. Skyler; A.D. Rogol; W. Lovenberg; R.A. Knazek

  Characterization of growth hormone and prolactin produced by human pituitary in culture

  Endocrinology. 1977;100(2):283-291.
  1

• 214.

  1977

  J.S. Skyler; A. Chrambach; C.H. Li

  Quantitative polyacrylamide gel electrophoresis and specific activities of human somatotropin and its derivatives

  Biochimica et Biophysica Acta. 1977;481(2):566-572.
  0

• 215.

  1977

  J.S. Skyler; G. Baumann; A. Chrambach

  A catalogue of isohormones of human growth hormone based on quantitative polyacrylamide gel electrophoresis

  Acta Endocrinologica, Supplement. 1977;85(sup 211).
  0

• 216.

  1977

  Jay S. Skyler; Andreas Chrambach; Choh Hao Li

  Quantitative polyacrylamide gel electrophoresis and specific activities of human somatotropin and its derivatives

  BBA - Protein Structure. 1977;491(2):566-572.
  0

• 217.

  1976

  Hans J. Zweerink; Exeen M. Morgan; Jay S. Skyler

  Reovirus morphogenesis: Characterization of subviral particles in infected cells

  Virology. 1976;73(2):442-453.
  13

• 218.

  1976

  D.C. Jimerson; R.M. Post; J. Skyler; W.E. Bunney

  Prolactin in cerebrospinal fluid and dopamine function in man

  Journal of Pharmacy and Pharmacology. 1976;28(11):845-847.
  1

• 219.

  1976

  S. Slater; C.E. De La Vega; J. Skyler; D.L. Murphy

  Plasma prolactin stimulation by fenfluramine and amphetamine

  Psychopharmacology Bulletin. 1976;12(4):26-27.
  3

• 220.

  1976

  R.A. Knazek; J.S. Skyler

  Polypeptide hormone production by cells cultured on artificial capillaries

  EXCERPTA MED. I.C.S. 1976;No. 381:386-395.
  0

• 221.

  1976

  D.C. Jimerson; R.M. Post; J. Skyler; W.E. Bunney Jr.

  A preliminary report: neuroendocrine effects of dopamine and norepinephrine receptor stimulators

  Psychopharmacology Bulletin. 1976;12(4):24-26.
  0

• 222.

  1976

  R.A. Knazek; J.S. Skyler

  Secretion of human prolactin in vitro

  Proceedings of the Society for Experimental Biology and Medicine. 1976;151(3):561-564.
  1

• 223.

  1975

  W. Kempner; B.C. Newborg; R.L. Peschel; J.S. Skyler

  Treatment of massive obesity with rice/reduction diet program. An analysis of 106 patients with at least a 45 kg weight loss

  Archives of Internal Medicine. 1975;135(12):1575-1584.
  6

• 224.

  1975

  J.M. Feldman; C.H. Bivens; J.S. Skyler; H.E. Lebovitz

  Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects

  Hormone and Metabolic Research. 1975;7(4):279-283.
  0

• 225.

  1974

  J.S. Skyler; G.J. Ellis III; C.H. Bivens

  Carolinas' camp for diabetic children. II. Descriptive features of a camper population with emphasis on complications

  North Carolina Medical Journal. 1974;35(1):29-32.
  2

• 226.

  1974

  J.S. Skyler; F.A. Neelon; W.J. Arnold; W.N. Kelly; H.E. Lebovitz

  Growth retardation in the Lesch Nyhan syndrome

  Acta Endocrinologica. 1974;75(1):3-10.
  0

• 227.

  1974

  J.S. Skyler

  Walter Kempner. A biographical note.

  Archives of Internal Medicine. 1974;133(5):752-755.
  3

• 228.

  1974

  J. Dranov; J.S. Skyler; J.C. Gunnells

  Malignant hypertension. Current modes of therapy

  Archives of Internal Medicine. 1974;133(5):791-801.
  0

• 229.

  1973

  J.S. Skyler

  Differential certification of physician's assistants.

  Archives of Internal Medicine. 1973;132(2):291.
  0

• 230.

  1973

  J.S. Skyler; G.J. Ellis III; H.K. Delcher

  Carolinas' camp for diabetic children. I. Report of first five years of operation

  North Carolina Medical Journal. 1973;34(12):935-938.
  0

• 231.

  1973

  N.M. Kredich; M.J. Skyler; L.J. Foote

  Antibodies to native DNA in systemic lupus erythematosus: a technique of rapid and quantitative determination

  Archives of Internal Medicine. 1973;131(5):639-644.
  5

• 232.

  1971

  J.S. Skyler

  Symposium on social issues and medicine. Concluding remarks.

  Archives of Internal Medicine. 1971;127(1):110.
  0

• 233.

  1971

  J.S. Skyler

  Symposium on social issues and medicine. Introductory remarks.

  Archives of Internal Medicine. 1971;127(1):49-50.
  0

• 234.

  1969

  J.S. Skyler

  Detecting hypothyroidism.

  Lancet. 1969;1(7588):259.
  0

• 235.

  1968

  J.S. Skyler

  Medical-student dissent deplored.

  New England Journal of Medicine. 1968;278(11):624-625.
  0